Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study

被引:12
|
作者
Aitken, Clare A. [1 ,2 ]
Inturrisi, Federica [3 ,4 ]
Kaljouw, Sylvia [1 ]
Nieboer, Daan [1 ]
Siebers, Albert G. [5 ]
Melchers, Willem J. G. [6 ]
van den Brule, Adriaan J. C. [7 ]
Molijn, Anco [8 ]
Hinrichs, John W. J. [9 ,10 ]
Niesters, Hubert G. M. [11 ]
van Kemenade, Folkert J. [2 ]
Berkhof, Johannes
de Kok, Inge M. C. M. [1 ,12 ]
机构
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam, Epidemiol & Data Sci, Amsterdam UMC locat, Amsterdam, Netherlands
[4] Amsterdam Publ Hlth, Methodol, Amsterdam, Netherlands
[5] PALGA Fdn, Nationwide Network & Registry Histo & Cytopathol N, Houten, Netherlands
[6] Radboud Univ Nijmegen, Med Microbiol, Med Ctr, Nijmegen, Netherlands
[7] Jeroen Bosch Hosp, Pathologie DNA, sHertogenbosch, Netherlands
[8] NMDL LCPL, DDL Diagnost Lab, Rijswijk, Netherlands
[9] Symbiant Pathol Expert Ctr Hoorn, Hoorn, Netherlands
[10] Univ Med Ctr Utrecht, Pathol, Utrecht, Netherlands
[11] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Div Clin Virol, Groningen, Netherlands
[12] Erasmus MC, Univ Med Ctr Rotterdam, Univ Med Ctr, Publ Hlth, NL-3000 CA Rotterdam, Netherlands
关键词
COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; NON-ATTENDEES; RISK; SMOKING;
D O I
10.1158/1055-9965.EPI-22-0712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In the Netherlands, lower high-risk human pap-illomavirus (hrHPV) positivity but higher cervical intraepithelial neoplasia (CIN) 2+ detection were found in self-collected com-pared with clinician-collected samples. To investigate the possible reason for these differences, we compared sociodemographic and screening characteristics of women and related these to screening outcomes.Methods: We extracted data from PALGA on all primary hrHPV screens and associated follow-up tests for 857,866 screened women, invited in 2017 and 2018. We linked these data with sociodemo-graphic data from Statistics Netherlands. Logistic regression was performed for hrHPV positivity and CIN 2+/3+ detection.Results: Out of the 857,866 women, 6.8% chose to use a self-sampling device. A higher proportion of self-sampling users was ages 30 to 35 years, was not previously screened, was living in a one-person household, or was the breadwinner in the household. After adjustment for these factors self-sampling had lower hrHPV positivity (aOR, 0.65; 95% CI, 0.63-0.68)) as compared with clini-cian-collected sampling, as well as lower odds of CIN 2+ (aOR, 0.76; 95% CI, 0.70-0.82) and CIN 3+ (aOR, 0.86; 95% CI, 0.78-0.95) detection.Conclusions: It is likely that the observed differences between the two sampling methods are not only related to sociodemographic differences, but related to differences in screening test accuracy and/ or background risk.Impact: Self-sampling can be used for targeting underscreened women, as a more convenient screening tool. Further investigation is required to evaluate how to implement self-sampling, when it is used as a primary instrument in routine screening.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 50 条
  • [41] ACCEPTABILITY OF SELF-SAMPLING HPV TESTING AMONG WOMEN ATTENDING IN AN INSTITUTION FOR CERVICAL CANCER SCREENING
    Oranratanaphan, S.
    Termrungruanglert, W.
    Khemapech, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 547 - 547
  • [42] Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial
    Zhang, Yi
    Du, Hui
    Wang, Chun
    Huang, Xia
    Qu, Xinfeng
    Wu, Ruifang
    INFECTIOUS AGENTS AND CANCER, 2024, 19 (01)
  • [43] Self-sampling HPV DNA test for cervical cancer screening in Singapore: A prospective study
    Lim, Li Min
    Chan, Ming Fen Grace
    Win, Pa Pa Thu
    Shen, Liang
    Arunachalam, Ilancheran
    Ng, Soon Yau Joseph
    Low, Jen Hui Jeffrey
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (11) : 733 - 735
  • [44] HPV self-sampling among cervical cancer screening nonattenders: a feasibility study in Estonia
    Hallik, R.
    Innos, K.
    Janes, J.
    Veerus, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [45] Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland
    Duke, Pauline
    Godwin, Marshall
    Ratnam, Samuel
    Dawson, Lesa
    Fontaine, Daniel
    Lear, Adrian
    Traverso-Yepez, Martha
    Graham, Wendy
    Ravalia, Mohamad
    Mugford, Gerry
    Pike, Andrea
    Fortier, Jacqueline
    Peach, Mandy
    BMC WOMENS HEALTH, 2015, 15
  • [46] Uptake of cervical screening and acceptability of HPV self-sampling in Irish Traveller women
    O'Flynn, A.
    Fitzpatrick, P.
    Jalal, R.
    Frazer, K.
    Joye, R.
    Collins, M. B.
    Kavanagh, L.
    Mccarthy, T.
    Mcenery, M.
    Fox, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [47] Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders
    Gok, Murat
    Heideman, Danielle A. M.
    van Kemenade, Folkert J.
    de Vries, Anton L. M.
    Berkhof, Johannes
    Rozendaal, Lawrence
    Belien, Jeroen A. M.
    Overbeek, Lucy
    Babovic, Milena
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (12) : 1799 - 1808
  • [48] Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
    Aitken, Clare A.
    van Agt, Heleen M. E.
    Siebers, Albert G.
    van Kemenade, Folkert J.
    Niesters, Hubert G. M.
    Melchers, Willem J. G.
    Vedder, Judith E. M.
    Schuurman, Rob
    van den Brule, Adriaan J. C.
    van der Linden, Hans C.
    Hinrichs, John W. J.
    Molijn, Anco
    Hoogduin, Klaas J.
    van Hemel, Bettien M.
    de Kok, Inge M. C. M.
    BMC MEDICINE, 2019, 17 (01)
  • [49] Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
    Clare A. Aitken
    Heleen M. E. van Agt
    Albert G. Siebers
    Folkert J. van Kemenade
    Hubert G. M. Niesters
    Willem J. G. Melchers
    Judith E. M. Vedder
    Rob Schuurman
    Adriaan J. C. van den Brule
    Hans C. van der Linden
    John W. J. Hinrichs
    Anco Molijn
    Klaas J. Hoogduin
    Bettien M. van Hemel
    Inge M. C. M. de Kok
    BMC Medicine, 17
  • [50] Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands
    Polman, Nicole J.
    de Haan, Yanne
    Veldhuijzen, Nienke J.
    Heideman, Danielle A. M.
    de Vet, Henrica C. W.
    Meijer, Chris J. L. M.
    Massuger, Leon F. A. G.
    van Kemenade, Folkert J.
    Berkhof, Johannes
    PREVENTIVE MEDICINE, 2019, 125 : 5 - 11